EUROQOL | News
ISPOR Podium Presentation in Baltimore, USA on United States Valuation Of EQ-5D-5L Health States – An Initial Model Using A Standardized Protocol
The EuroQol Group is pleased to announce a podium presentation at the ISPOR 23rd International Meeting in Baltimore, USA on Monday 21 May from 5:00 PM - 6:00 PM, entitled: United States Valuation Of EQ-5D-5L…
PharmacoEconomics publishes series of articles on the EQ-5D-5L
The journal PharmacoEconomics has recently published online a series of four articles and two commentaries on the five level version of the EQ-5D (EQ-5D-5L). One article reports the first head-to-head comparison of the descriptive systems…
35th EQ Plenary Meeting 2018
The Call for Abstracts for the 35th EuroQol Group Scientific Plenary Meeting in Lisbon, Portugal on 19-22 September 2018 is now closed!
Dutch EQ-5D-5L article is the third most downloaded paper in Value in Health 2016
High levels of interest in the EQ-5D-5L are demonstrated by the article by Versteegh et al (2016), who established the Dutch tariff for the EQ-5D-5L , being third in the list of most popular downloads…
Is NICE ready to take EQ-5D to the next level?
At the 2017 ISPOR European Congress, a workshop was organised where representatives from the National Institute for Health and Care Excellence (NICE), the University of Sheffield, the Office of Health Economics (OHE), London and the…
New publications EuroQol Working Paper Series
The EuroQol Group has published two new Working Paper Series Manuscripts: Oppe M and Craig B. Conceptual issues with Health Valuation and its Underlying Assumptions Oppe M and Van Hout B. The “power” of eliciting…
A Lifetime of Achievement: A Profile of Paul Kind
Paul Kind, a founding member of the EuroQol Group, has won the ISPOR’s 2017 Avedis Donabedian Outcomes Research Lifetime Achievement Award. The Award recognizes an individual's outstanding, life-long achievement in the area of improving health…
‘Extending the QALY’ project collaboration with NICE
NICE is taking part in a project that will examine how quality of life measures used to evaluate healthcare treatments such as drugs can be extended into areas of social care and public health. The…
- 1
- 2